Top Stock Movers Today — July 27, 2026: Why ENTX, FBRX, NIPG & QBTS Surged

ENTX — Entera Bio Ltd. (+90.7%)

Entera Bio closed at $3.91, nearly doubling in a single session on volume of 64,353,820 shares — roughly 18.6× its 20-day average of 3,460,838. That kind of volume surge on a sub-$5 stock signals a significant, company-specific catalyst rather than broad market momentum.

Why it moved: Entera Bio announced the pricing of an oversubscribed $275 million private placement (per Yahoo Finance). A "private placement" is a sale of shares directly to institutional investors outside the open market; "oversubscribed" means investor demand exceeded the amount on offer — a strong vote of confidence from sophisticated buyers. The deal dramatically expands the company's balance sheet and, for a small-cap healthcare name, can signal a meaningful acceleration in development plans. The stock gapped up 43.4% at the open and extended gains through the close, setting a fresh 52-week high.

Technical picture: StockSetups assigned ENTX a conviction score of 82/100 and a grade of A, with a technical rank of 99 and an RS rating of 97 — placing it among the very top performers in the full US universe on a relative-strength basis. RSI hit 90 and ADX printed 65, indicating an extremely strong and trending move. The MA stack is mixed, suggesting the stock was rebasing before today's explosion. With a squeeze score of just 29/100 and short interest of only 297,452 shares (1.3 days to cover), this move was almost entirely catalyst-driven rather than a short squeeze.

As always with a stock that nearly doubles in one day, much of the gain can unwind quickly once the initial excitement fades — especially after a dilutive capital raise, which increases the total share count.

FBRX — Forte Biosciences, Inc. (+39.7%)

Forte Biosciences closed at $76.53, up 39.7% on volume of 35,364,560 shares — about 13.3× its 20-day average of 2,660,840. This was one of the most heavily traded healthcare names in the US market on July 27.

Why it moved: argenx agreed to acquire Forte Biosciences in a $2.2 billion deal, according to multiple sources including Biopharmadive and Proactive Investors. The acquisition targets Forte's "differentiated" immune drug pipeline. In a buyout announcement, the acquirer typically offers a premium above the target's pre-deal price; that premium is what drove the 39.5% opening gap and pushed FBRX to its highest levels in over 4.5 years (per Stocktwits). This is a confirmed M&A catalyst — straightforward and authoritative.

Technical picture: StockSetups rated FBRX at the top of its scale: conviction 96/100, grade A+, technical rank 99, RS rating 97. RSI reached 86 and ADX 60, confirming strong trend momentum. The MA stack is fully bullish. The squeeze score of 64/100 is notable — with 2,060,636 shares short and 1.7 days to cover (meaning it would take short sellers roughly 1.7 days of average volume to buy back all their positions), there was likely a forced short-covering component layered on top of the M&A premium. The largest disclosed institutional stake is 10.3%. FBRX has now appeared in StockSetups recaps before — it was among the top movers on July 9, 2026.

Buyout deals can occasionally fall through or be renegotiated; trading a confirmed acquisition at a premium to the announcement price carries its own risks.

NIPG — NIP Group Inc. (+35.4%)

NIP Group closed at $20.99, up 35.4% on 23,140,317 shares — roughly 18.9× its 20-day average of 1,222,598. The stock gapped up 27.6% at the open and continued higher through the session, ending at a fresh 52-week high.

Why it moved: No specific catalyst headline is on file for today's session. The most recent SEC filings are 6-K foreign-event reports dated July 24, July 1, and June 30 — all flagged neutral. With the catalyst unclear, this looks like a momentum- and technically-driven move, though a news item may have emerged in Chinese-language or overseas media given NIPG's structure as a foreign-listed consumer discretionary company.

What the data does tell us: NIPG has an extraordinarily low free float of just 10.3% — meaning only about one in ten shares is freely tradable by the public. A "low float" stock like this can move violently on relatively modest buying pressure because there simply aren't many shares available for trading. With short interest of just 3,691 shares (0.3 days to cover), a squeeze is not the driver here. StockSetups awarded NIPG its highest possible scores: conviction 100/100, technical rank 100, grade A+, RS rating 99, and trend-template score 8. RSI printed 90 and ADX 62.

One technical flag worth watching: the session printed a shooting star candlestick — a pattern where the price rallies sharply intraday but closes near the bottom of the day's range, leaving a long upper shadow. It can signal that buyers are losing control near the highs and a pullback may follow. NIPG has been a recurring name in StockSetups recaps — it featured in the July 24, July 22, and July 21 after-close editions.

QBTS — D-Wave Quantum Inc. (+20.3%)

D-Wave Quantum closed at $19.50, up 20.3% on 37,344,843 shares — about 2.0× its 20-day average of 18,289,940. Unlike the other movers today, QBTS is a larger, more liquid name with a market cap of $7.2 billion.

Why it moved: No specific catalyst headline is on file for today, and the recent SEC filings — a Reg FD 8-K from July 24, an insider sale notice from July 20, and a delisting-related 8-K from July 14 (flagged bearish) — do not point to a clear positive fundamental driver. The move looks primarily technical and short-squeeze driven.

Here's why: QBTS carries a squeeze score of 85/100 — one of the highest readings in today's scan. Short interest stands at 65,067,516 shares, and with a days-to-cover ratio of 3.7 (meaning it would take short sellers approximately 3.7 days of average trading volume to unwind their bets), any upward price pressure can cascade as shorts rush to buy back shares simultaneously. That self-reinforcing dynamic is a short squeeze — and with 62% of today's volume flowing through the short side, there is clear evidence of forced covering. The stock also gapped up 10.8% at the open.

That said, QBTS's broader technical picture is weak: RSI of 48, ADX of just 26, a fully bearish MA stack, and the stock is still 56.5% below its 52-week high. StockSetups reflects this — conviction score of just 24/100, technical rank 22, grade D, trend-template score 1. Reddit buzz placed QBTS at rank #59 across r/all-stocks with 9 mentions today. A one-day short-squeeze pop in a structurally weak chart is among the highest-risk trades a trader can take; the squeeze can reverse with equal speed.

The bottom line

Today's four biggest gainers illustrate how differently a 20–90% single-day move can be built: a company-specific capital raise (ENTX), a confirmed M&A premium (FBRX), low-float momentum (NIPG), and a short squeeze in a structurally weak chart (QBTS). Every one of those setups carries meaningful reversal risk — big one-day gains regularly give back a significant portion in the days that follow, and patterns, squeezes, and deal speculation can all fail. None of this is financial advice or a recommendation to buy or sell any security. Always size positions with your own risk tolerance and do your own research before acting.

StockSetups scans the full ~12,300-stock US universe after every close, detects chart patterns confirmed by candlesticks, and ranks long setups by conviction score, short-squeeze score, relative strength, and smart-money signals — so you can see which names are setting up, breaking out, or retesting before the next session opens.